Chargement en cours...
Spotlight on elotuzumab in the treatment of multiple myeloma: the evidence to date
Despite advances in the treatment of multiple myeloma, it remains an incurable disease, with relapses and resistances frequently observed. Recently, immunotherapies, in particular, monoclonal antibodies, have become important treatment options in anticancer therapies. Elotuzumab is a humanized monoc...
Enregistré dans:
| Publié dans: | Onco Targets Ther |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5063562/ https://ncbi.nlm.nih.gov/pubmed/27785050 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S94531 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|